Back to Authors

Chen, Kelly

0009-0002-8071-6641

A5101619583

Mayo Clinic

Prilenia Therapeutics B.V

Citations 2

Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | December 17, 2025 | Volume: 27 | Issue: 3-4 | Pages: 432-444

10.1080/21678421.2025.2597935 | PMID 41406304

Pridopidine for the Treatment of ALS–Improvements in the Subgroup of Definite, Probable, and Early (

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211988